IPO Year: 2024
Exchange: NASDAQ
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - iTonic Holdings Ltd (0001970544) (Issuer)
3 - iTonic Holdings Ltd (0001970544) (Issuer)
3 - iTonic Holdings Ltd (0001970544) (Issuer)
Fastest customizable press release news feed in the world
BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") that Nasdaq approved the Company's request for an extension of additional 180-calendar day, or until October 19, 2026 (the "Extension") to regain compliance with the minimum closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule").The Extension follows the expiration the initial 180-calendar day compliance p
6-K - iTonic Holdings Ltd (0001970544) (Filer)
20-F/A - iTonic Holdings Ltd (0001970544) (Filer)
20-F - iTonic Holdings Ltd (0001970544) (Filer)
6-K - iTonic Holdings Ltd (0001970544) (Filer)
EFFECT - iTonic Holdings Ltd (0001970544) (Filer)
6-K - iTonic Holdings Ltd (0001970544) (Filer)